215 related articles for article (PubMed ID: 29700912)
1. Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.
Ozturk E; Aksoy SA; Ugras N; Tunca B; Ceylan S; Tezcan G; Yilmazlar T; Yerci O; Egeli U; Cecener G
APMIS; 2018 Feb; 126(2):99-108. PubMed ID: 29700912
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
Lai WW; Wu MH; Yan JJ; Chen FF
Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
[TBL] [Abstract][Full Text] [Related]
3. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
4. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.
Friess H; Guo XZ; Tempia-Caliera AA; Fukuda A; Martignoni ME; Zimmermann A; Korc M; Büchler MW
J Clin Oncol; 2001 May; 19(9):2422-32. PubMed ID: 11331321
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.
Liu YB; Gao SL; Chen XP; Peng SY; Fang HQ; Wu YL; Peng CH; Tang Z; Xu B; Wang JW; Deng GL; Li HJ; Feng XD; Qian HR
World J Gastroenterol; 2005 Mar; 11(9):1378-81. PubMed ID: 15761980
[TBL] [Abstract][Full Text] [Related]
7. nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma.
Kapitanović S; Cacev T; Berković M; Popović-Hadzija M; Radosević S; Seiwerth S; Spaventi S; Pavelić K; Spaventi R
J Clin Pathol; 2004 Dec; 57(12):1312-8. PubMed ID: 15563674
[TBL] [Abstract][Full Text] [Related]
8. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.
Nitsche U; Rosenberg R; Balmert A; Schuster T; Slotta-Huspenina J; Herrmann P; Bader FG; Friess H; Schlag PM; Stein U; Janssen KP
Ann Surg; 2012 Nov; 256(5):763-71; discussion 771. PubMed ID: 23095620
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
10. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
Cheah PY; Cao X; Eu KW; Seow-Choen F
Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
[TBL] [Abstract][Full Text] [Related]
11. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
12. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients.
Lederer A; Herrmann P; Seehofer D; Dietel M; Pratschke J; Schlag P; Stein U
Hepatology; 2015 Sep; 62(3):841-50. PubMed ID: 25953673
[TBL] [Abstract][Full Text] [Related]
13. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
14. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
15. nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma.
Boix L; Bruix J; Campo E; Sole M; Castells A; Fuster J; Rivera F; Cardesa A; Rodes J
Gastroenterology; 1994 Aug; 107(2):486-91. PubMed ID: 8039626
[TBL] [Abstract][Full Text] [Related]
16. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
17. The role of nm23-H1 in the progression of transitional cell bladder cancer.
Chow NH; Liu HS; Chan SH
Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of nm23 protein expression in renal cell carcinomas.
Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
[TBL] [Abstract][Full Text] [Related]
19. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
20. A high nuclear nm23-H1 expression is associated with a better prognosis in elderly patients with laryngeal carcinoma.
Lionello M; Blandamura S; Lovato A; Franchella S; Giacomelli L; Ottaviano G; Stellini E; Staffieri A; Marioni G
Acta Otolaryngol; 2013 Aug; 133(8):874-80. PubMed ID: 23768014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
